Veriphi crowdfunds again to reach commercialisation
The medical tech company has faced some setbacks since last year's round.
Local medical technology company Veriphi is equity crowdfunding again, to fund its path to commercialisation.
The Devonport-based start-up, which has developed laser technology to identify drugs, hopes to prevent people dying or being injured after receiving the wrong intravenous medication in
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Fri, 19 Jan 2018
Fri, 19 Jan 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Related News
Related News
Veriphi crowdfunds again to reach commercialisation
72841